http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IN-2013MN00441-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d05175aa9dc4232d9e01d88900f7e0b6 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-347 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 |
| filingDate | 2011-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dbe8adc4d868f3c64acc26393040884 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04c2943b6220faea349acdf2933a378e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b024c2600a802674b9b9c346f5fd5095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90c4e7348f14e4ed0e8bbdb22671d6a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea7ca24db7f6b0097e745b0724538101 |
| publicationDate | 2015-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IN-2013MN00441-A |
| abstract | The present invention relates to methods and compositions for monitoring diagnosis prognosis and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular the invention relates to using assays that detect one or more biomarkers selected from the group consisting of Beta nerve growth factor Interleukin 17A Follitropin subunit beta Collagenase 3 Follistatin Vitamin D Binding Protein Islet amyloid polypeptide Insulin C peptide Complement Factor H Gastric inhibitory polypeptide Glucagon like peptide 1 Glucagon Involucrin Type II cytoskeletal Keratin 1/Keratin 10 Type II cytoskeletal Keratin 6 A/6B/6C Osteocalcin Lipopolysaccharide Pancreatic prohormone Peptide YY Agouti related protein Ciliary neurotrophic factor Appetite regulating hormone Transthyretin Insulin receptor substrate 1 and NF kappa B inhibitor alpha as diagnostic and prognostic biomarker assays in renal injuries. |
| priorityDate | 2010-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 404.